Finance

Lists
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
၄၈၄.၈၀ SEK
+၀.၉၆%
(+၄.၆၀) 1D
နို ၁၁, GMT+၁ ၁၅:၂၀:၁၅  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for SOBI...
Open
၄၈၃.၆၀ SEK
High
၄၈၅.၆၀ SEK
Low
၄၇၉.၄၀ SEK
Mkt. cap
ဋေ ၁.၇၃ သ
Avg. vol.
၃.၈၅ သိန်း
Volume
၇.၆၄ သောင်း
P/E ratio
၂၅.၇၅
52-wk high
၅၀၇.၀၀ SEK
52-wk low
၃၁၄.၄၀ SEK
EPS
၁၈.၈၃ SEK
Shares outstanding
၃၅.၇၆ ကုဋေ
No. of employees
၂ ထောင်
Open
၄၈၃.၆၀ SEK
High
၄၈၅.၆၀ SEK
Low
၄၇၉.၄၀ SEK
Mkt. cap
ဋေ ၁.၇၃ သ
Avg. vol.
၃.၈၅ သိန်း
Volume
၇.၆၄ သောင်း
P/E ratio
၂၅.၇၅
52-wk high
၅၀၇.၀၀ SEK
52-wk low
၃၁၄.၄၀ SEK
EPS
၁၈.၈၃ SEK
Shares outstanding
၃၅.၇၆ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Barchart.com
Barchart.com
·
ပြီးခဲ့သည့် ၅၀ မိနစ်
Nasdaq Futures Rally as CoreWeave and Anthropic Fuel AI Optimism
PR Newswire Canada
PR Newswire Canada
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
NYSE Honors Those Who Have Served on Veterans Day: NYSE Content Update
Reuters
Reuters
·
ပြီးခဲ့သည့် ၃ နာရီ
Mapping the Market: S&P 500 at risk of further losses
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA. Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)
CEOGuido Oelkers
Employees၂.၂၁ ထောင်
Founded၁၉၃၉
Headquarters-
SectorHealth Care
Industry-
Websitesobi.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၇၈၂.၁၀ ဋေ
၇၁၈.၄၀ ဋေ
၇၈၄.၂၀ ဋေ
၉၁၂.၄၀ ဋေ
Cost of goods sold
၁၅၁.၄၀ ဋေ
၁၇၀.၄၀ ဋေ
၁၈၂.၉၀ ဋေ
၁၉၂.၉၀ ဋေ
Cost of revenue
၁၅၁.၄၀ ဋေ
၁၇၀.၄၀ ဋေ
၁၈၂.၉၀ ဋေ
၁၉၂.၉၀ ဋေ
Research and development expenses
၈၇.၉၀ ကုဋေ
၉၄.၈၀ ကုဋေ
၁၁၃.၀၀ ဋေ
၁၀၇.၁၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၉၂.၉၀ ဋေ
၂၆၂.၁၀ ဋေ
၂၈၉.၄၀ ဋေ
၂၈၂.၈၀ ဋေ
Operating expense
၃၇၅.၁၀ ဋေ
၃၅၇.၀၀ ဋေ
၄၀၃.၂၀ ဋေ
၃၈၇.၃၀ ဋေ
Total operating expenses
၅၂၆.၅၀ ဋေ
၅၂၇.၄၀ ဋေ
၅၈၆.၁၀ ဋေ
၅၈၀.၂၀ ဋေ
Operating income
၂၅၅.၆၀ ဋေ
၁၉၁.၀၀ ဋေ
၁၉၈.၁၀ ဋေ
၃၃၂.၂၀ ဋေ
Other non operating income
-၂.၅၀ ကုဋေ
၁.၀၀ သန်း
၁.၀၀ သန်း
၁.၀၀ သန်း
EBT including unusual items
၂၁၇.၂၀ ဋေ
၁၆၈.၁၀ ဋေ
၁၄၁.၃၀ ဋေ
၃၀၃.၈၀ ဋေ
EBT excluding unusual items
၂၃၁.၅၀ ဋေ
၁၇၂.၄၀ ဋေ
၁၇၆.၈၀ ဋေ
၃၁၃.၆၀ ဋေ
Income tax expense
၃၁.၀၀ ကုဋေ
၃၆.၃၀ ကုဋေ
၃၁.၅၀ ကုဋေ
၆၈.၉၀ ကုဋေ
Effective tax rate
၁၄.၂၇%
၂၁.၅၉%
၂၂.၂၉%
၂၂.၆၈%
Other operating expenses
-၅.၇၀ ကုဋေ
၁.၀၀ သန်း
၈.၀၀ သန်း
-၂.၆၀ ကုဋေ
Net income
၁၈၆.၂၀ ဋေ
၁၃၁.၈၀ ဋေ
၁၀၉.၇၀ ဋေ
၂၃၅.၀၀ ဋေ
Net profit margin
၂၃.၈၁%
၁၈.၃၅%
၁၃.၉၉%
၂၅.၇၆%
Earnings per share
၅.၆၅
၄.၀၇
၃.၉၆
၆.၈၉
Interest and investment income
၂.၂၀ ကုဋေ
-
-
-
Interest expense
-၁၅.၆၀ ကုဋေ
-၁၇.၃၀ ကုဋေ
-၂၀.၄၀ ကုဋေ
-၂၀.၄၀ ကုဋေ
Net interest expenses
-၁၃.၄၀ ကုဋေ
-၁၇.၃၀ ကုဋေ
-၂၀.၄၀ ကုဋေ
-၂၀.၄၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၁၃.၀၀ ဋေ
၂၆၉.၂၀ ဋေ
၂၇၈.၅၀ ဋေ
၄၁၃.၂၀ ဋေ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ